MS drug costs nearly triple over 7 years, even with introduction of generic, study finds

The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study published in the January 15, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.